UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Three-dimensional simulation of polymer electrolyte membrane fuel cells with experimental validation

Electrochimica acta, 2011-12, Vol.56 (28), p.10820-10831

2011

Volltextzugriff (PDF)

Electrothermal and Electrochemical Modeling of Lithium-ion Batteries: 3D Simulation with Experimental Validation

ECS transactions, 2014, Vol.61 (27), p.105-124

2014

Volltextzugriff (PDF)

Development of a Segmented Single SOFC Test Equipment to Simulate Stack-Like Operating Conditions

ECS transactions, 2017-05, Vol.78 (1), p.2115-2132

2017

Volltextzugriff (PDF)

Method for Determination of the Internal Short Resistance and Heat Evolution at Different Mechanical Loads of a Lithium Ion Battery Cell Based on Dummy Pouch Cells

Batteries (Basel), 2016-06, Vol.2 (2), p.8

2016

Volltextzugriff (PDF)

Three-dimensional simulation of polymer electrolyte membrane fuel cells with experimental validation

Electrochimica acta, 2011, Vol.56 (28), p.10820-10831

2011

Volltextzugriff (PDF)

Numerical simulation of squirrel cage induction machine

2021 IEEE Vehicle Power and Propulsion Conference (VPPC), 2021, p.1-6

2021

Volltextzugriff (PDF)

Comparison of Electrochemical and Electrothermal Models for Lithium-Ion Batteries Used in 3D Simulation

Meeting abstracts (Electrochemical Society), 2014-04, Vol.MA2014-01 (1), p.82-82

2014

Volltextzugriff (PDF)

Development of a Segmented Single SOFC Test Equipment to Simulate Stack-Like Operating Conditions

Meeting abstracts (Electrochemical Society), 2017-07, Vol.MA2017-03 (1), p.270-270

2017

Volltextzugriff (PDF)

Li-Oxygen Versus Li-Ion Battery Systems: Chances and Challenges for Utilization in the Automotive Industry

Meeting abstracts (Electrochemical Society), 2014-06, Vol.MA2014-04 (3), p.557-557

2014

Volltextzugriff (PDF)

Locally Resolved Current and Voltage Distribution in Straight Flow Channels Compared with Multiphase CFD Simulation Results

Meeting abstracts (Electrochemical Society), 2008-08, Vol.MA2008-02 (11), p.871-871

2008

Volltextzugriff (PDF)

Die Kunst der Theatereröffnung: Ästhetik und Sozialgeschichte Von Bühnenprologen

1, 2023

Volltextzugriff (PDF)

A systematic review of neurological symptoms and complications of COVID-19

Journal of neurology, 2021-02, Vol.268 (2), p.392-402

2021

Volltextzugriff (PDF)

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Blood, 2023-08, Vol.142 (5), p.446-459

2023

Volltextzugriff (PDF)

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

The lancet oncology, 2016-07, Vol.17 (7), p.928-942

2016

Volltextzugriff (PDF)

Associations of recent weight loss with health care costs and utilization among older women

PloS one, 2018-01, Vol.13 (1), p.e0191642-e0191642

2018

Volltextzugriff (PDF)

Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2‐BCG): Final analysis of a multicenter, open‐label phase‐II‐trial

American journal of hematology, 2024-06, Vol.99 (6), p.1192-1195

2024

Volltextzugriff (PDF)

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

Journal of clinical oncology, 2012-09, Vol.30 (26), p.3209-3216

2012

Volltextzugriff (PDF)

Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial

The lancet oncology, 2018-09, Vol.19 (9), p.1215-1228

2018

Volltextzugriff (PDF)

Health‐related quality of life with fixed‐duration venetoclax‐obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial

American journal of hematology, 2021-09, Vol.96 (9), p.1112-1119

2021

Volltextzugriff (PDF)

Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

Journal of clinical oncology, 2021-12, Vol.39 (36), p.4049-4060

2021

Volltextzugriff (PDF)

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

The New England journal of medicine, 2023-05, Vol.388 (19), p.1739-1754

2023

Volltextzugriff (PDF)

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

Journal of clinical oncology, 2012-03, Vol.30 (9), p.980-988

2012

Volltextzugriff (PDF)

Neue Therapieoptionen bei Neuromyelitis- optica-Spektrum-Erkrankung

InFo Neurologie + Psychiatrie, 2024-09, Vol.26 (9), p.30-41

2024

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(202)
Deutsch
(15)
Japanisch
(14)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(85)
Humans
(62)
Female
(40)
Male
(40)
Middle Aged
(36)
Aged
(35)
Hematology
(33)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(28)
Oncology
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Adult
(18)
Aged, 80 And Over
(18)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(16)
Chronic Lymphocytic Leukemia
(16)
Neurosciences & Neurology
(15)
Leukemia
(14)
Leukemia, Lymphocytic, Chronic, B-Cell - Mortality
(14)
Patients
(14)
Clinical Neurology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Three-dimensional simulation of polymer electrolyte membrane fuel cells with experimental validation

Electrothermal and Electrochemical Modeling of Lithium-ion Batteries: 3D Simulation with Experimental Validation

Development of a Segmented Single SOFC Test Equipment to Simulate Stack-Like Operating Conditions

Method for Determination of the Internal Short Resistance and Heat Evolution at Different Mechanical Loads of a Lithium Ion Battery Cell Based on Dummy Pouch Cells

Three-dimensional simulation of polymer electrolyte membrane fuel cells with experimental validation

Numerical simulation of squirrel cage induction machine

Comparison of Electrochemical and Electrothermal Models for Lithium-Ion Batteries Used in 3D Simulation

Development of a Segmented Single SOFC Test Equipment to Simulate Stack-Like Operating Conditions

Li-Oxygen Versus Li-Ion Battery Systems: Chances and Challenges for Utilization in the Automotive Industry

Locally Resolved Current and Voltage Distribution in Straight Flow Channels Compared with Multiphase CFD Simulation Results

Die Kunst der Theatereröffnung: Ästhetik und Sozialgeschichte Von Bühnenprologen

A systematic review of neurological symptoms and complications of COVID-19

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Associations of recent weight loss with health care costs and utilization among older women

Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2‐BCG): Final analysis of a multicenter, open‐label phase‐II‐trial

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial

Health‐related quality of life with fixed‐duration venetoclax‐obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial

Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

Neue Therapieoptionen bei Neuromyelitis- optica-Spektrum-Erkrankung

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

Suchergebnisse filtern